The North America Sample Preparation Market focuses on tools and technologies used in the preparation of analytical samples across various sectors such as pharmaceuticals, biotechnology, food, and environmental testing. With significant advancements in laboratory automation and rising investments in life sciences R&D, the region is witnessing major growth, especially in the United States and Canada. The market is highly fragmented and competitive, with leading players continuously innovating to offer faster, more reliable, and user-friendly sample preparation solutions.
The economic impact of tariffs on "North America Sample Preparation Market".
Market Growth Drivers
Rise in Pharmaceutical and Biotechnology Research: The expanding R&D investments by major pharmaceutical companies such as Thermo Fisher Scientific and Agilent Technologies are driving demand for advanced sample preparation systems. The growing prevalence of chronic diseases, innovative drug discovery processes, and the advent of biologics are fueling requirements for precise, high-throughput, and automated sample handling systems. For example, in 2023, Thermo Fisher Scientific announced further expansion of its R&D infrastructure in the US to support more advanced lab workflows, including automated sample preparation platforms.
Growth in Environmental Testing Regulations: The tightening of environmental regulations in North America has led to increased proactivity among industrial manufacturers and government laboratories to invest in cutting-edge analytical methods. Companies such as PerkinElmer are capitalizing on this trend by launching automated sample prep workflows for environmental pollutants testing, enabling faster turnaround and compliance with regulatory standards. Stringent monitoring for water, soil, and air sample testing in the US and Canada is thus a vital driver for the sample preparation market.
Market Trends
Integration of Artificial Intelligence & Automation: The trend toward lab automation and the application of AI in sample preparation workflows is transforming laboratory efficiency and data integrity in North America. Companies like Hamilton Company have introduced AI-powered robots capable of managing repetitive sample prep tasks, reducing human error and increasing throughput in genomics, proteomics, and clinical laboratories. This makes high-throughput labs more efficient and cost-effective, addressing the shortage of skilled lab technicians.
Rising Adoption of Microfluidics & Miniaturization: There is a growing trend in microfluidic-based sample preparation platforms, allowing for minimal sample volumes, reduced reagents, and faster results. Firms such as Illumina and Agilent are investing in miniaturized devices that seamlessly integrate sample prep with downstream analytics. The compact design and digitized workflows support point-of-care diagnostics and on-site testing applications across clinical and environmental sectors.
Market Opportunities
Expansion in Personalized Medicine Applications: Companies like QIAGEN and Bio-Rad are investing in sample prep products tailored for genomics and personalized healthcare, providing growth opportunities in precision diagnostics and targeted therapies as demand surges.
Partnerships with Academic and Research Institutions: Collaboration of market players such as Promega with leading universities to co-develop innovative sample preparation kits enables penetration into novel research domains, broadening end-user reach and technological adoption.
North America Sample Preparation Market Revenue (USD Million), 2020-2035
The revenue chart demonstrates a steady and consistent growth trajectory in the North America Sample Preparation Market from 2020 to 2035. In 2020, the market revenue stood at approximately USD 1,350 million and by 2025, it is projected to reach USD 1,890 million. Growth accelerates post-2027, driven by technological innovations, rising life science investments, and increased environmental regulatory scrutiny. By 2035, the market revenue is forecasted to reach USD 3,960 million, representing a robust CAGR of 7.2% from 2024 to 2035. This upward trend highlights the region’s leadership in life sciences, ongoing innovation across laboratory workflows, and the increasing integration of automation and AI in sample preparation processes.
North America Sample Preparation Market by Region, Share (%) in 2025
In 2025, the United States dominates the North America Sample Preparation Market, accounting for 67% of the total market share owing to its advanced research infrastructure and major laboratory investments. Canada follows with 19% share, driven by government initiatives in life sciences and environmental monitoring. Mexico holds a 7% share as industrial development and quality compliance regulations advance. Latin American countries and ‘Others’ (Caribbean territories) combine for the remaining 7%, reflecting smaller but emerging adoption of sample preparation technologies. The pie chart underlines the market’s concentration in the US while highlighting opportunities for growth in neighboring regions as laboratory research intensifies.
Recent Developments in the North America Sample Preparation Market (Jan-Jun 2024)
In March 2024, Thermo Fisher Scientific announced the launch of its new AutoPrep 500 Series instrument in North America, providing fully automated, high-throughput sample preparation for applications in genomics, proteomics, and clinical labs. The system features real-time remote monitoring, onboard liquid handling, and compatibility with next-generation sequencing workflows. This launch positions Thermo Fisher to address increasing demand for reliable, error-reducing sample prep solutions in both research and diagnostics.
As of May 2024, Agilent Technologies expanded its Santa Clara, CA, manufacturing site to include a new line dedicated to its SurePrep sample preparation kits. The expansion will focus on increasing production capacity and accelerating the development of novel prep kits for food safety and environmental testing, reinforcing Agilent’s leadership in supporting regulatory compliance and method validation across laboratories in North America.
In April 2024, QIAGEN partnered with the University of Toronto to co-develop a new portable sample preparation device for point-of-care molecular diagnostics. The collaboration focuses on integrating QIAGEN’s nucleic acid purification technologies with microfluidic platforms, making sample prep equipment more accessible and efficient for settings beyond centralized labs. This development is expected to hasten the adoption of rapid molecular testing in remote or resource-limited environments throughout North America.
Press Releases